Non-Steroidal Treatment Options for Plaque Psoriasis

Linda Stein Gold, MD, and Jennifer Soung, MD, provide an overview of the different, evidence-based topical strategies for treating plaque psoriasis.

Jennifer Soung, MD, provides an overview of the phase III trials, DERMIS-1/DERMIS-2, in which roflumilast was used to treat plaque psoriasis

Experts in plaque psoriasis discuss the primary endpoint data responses of roflumilast in the DERMIS-1/DERMIS-2 trials.

Linda Stein Gold, MD, discusses the itch response of roflumilast for the treatment for plaque psoriasis.

Linda Stein Gold, MD, and Jennifer Soung, MD, provides an overview of the safety profile and topical vehicle of roflumilast for the treatment of plaque psoriasis.

Linda Stein Gold, MD, reviews phase III data for the topical agent tapinarof for the treatment of plaque psoriasis.

Experts in plaque psoriasis provide an overview of the itch response and tolerability profile of tapinarof.

Jennifer Soung, MD, review long term data for tapinarof for the treatment of plaque psoriasis.

Linda Stein Gold, MD, and Jennifer Soung, MD, discuss real world experience of using roflumilast for plaque psoriasis therapy.

Experts describe roflumilast patient selection for plaque psoriasis treatment.